SYRE
Spyre Therapeutics Inc.
$88.34
+$0.85(+0.97%)
57
Overall
60
Value
91
Tech
21
Quality
Market Cap
$1.65B
Volume
2.42M
52W Range
$14.00 - $90.99
Target Price
$96.07
EPS Estimates Overview
| Current Quarter | $-0.73 | Next Quarter | $-0.72 |
| Current Year | $-2.86 | Next Year | $-3.31 |
| QoQ Growth | +1.4% | YoY Growth | -15.7% |
| 3Y EPS CAGR | +56.9% | Target Price | $96.07 |
| Consensus | Buy | Upside | +8.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $88.34 | +1.0% | 2.42M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |